<ddi:DDIInstance xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="ddi:instance:3_3 http://ddialliance.org/Specification/DDI-Lifecycle/3.3/XMLSchema/instance.xsd" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ddi="ddi:instance:3_3" xmlns:r="ddi:reusable:3_3" xmlns:s="ddi:studyunit:3_3" xmlns:d="ddi:datacollection:3_3" xmlns:a="ddi:archive:3_3" xmlns:c="ddi:conceptualcomponent:3_3" xmlns:cm="ddi:comparative:3_3" xmlns:g="ddi:group:3_3" xmlns:l="ddi:logicalproduct:3_3" xmlns:p="ddi:physicaldataproduct:3_3" xmlns:pi="ddi:physicalinstance:3_3" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:xml="http://www.w3.org/XML/1998/namespace" isMaintainable="true" scopeOfUniqueness="Agency">
  <r:URN>urn:ddi:se.researchdata:doi-10-17044-scilifelab-21557163:0</r:URN>
  <r:Agency>SND</r:Agency>
  <r:ID>doi-10-17044-scilifelab-21557163</r:ID>
  <r:Version>0</r:Version>
  <g:ResourcePackage>
    <r:URN>urn:ddi:se.researchdata:doi-10-17044-scilifelab-21557163.ResourcePackage:2.0</r:URN>
    <r:OtherMaterialScheme>
      <r:URN>urn:ddi:se.researchdata:doi-10-17044-scilifelab-21557163.OtherMaterialScheme:2.0</r:URN>
    </r:OtherMaterialScheme>
    <a:OrganizationScheme>
      <r:URN>urn:ddi:se.researchdata:doi-10-17044-scilifelab-21557163.OrganizationScheme-0:2.0</r:URN>
      <a:Individual>
        <r:URN>urn:ddi:se.researchdata:doi-10-17044-scilifelab-21557163.Individual-0:2.0</r:URN>
        <r:UserAttributePair>
          <r:AttributeKey>affiliation</r:AttributeKey>
          <r:AttributeValue>Science for Life Laboratory</r:AttributeValue>
        </r:UserAttributePair>
        <a:IndividualIdentification>
          <a:IndividualName>
            <a:FirstGiven>Henrik</a:FirstGiven>
            <a:LastFamily>Lilljebjörn</a:LastFamily>
            <a:FullName>
              <r:String>Henrik Lilljebjörn</r:String>
            </a:FullName>
          </a:IndividualName>
          <a:ResearcherID>
            <a:TypeOfID>ORCID</a:TypeOfID>
            <a:ResearcherIdentification>0000-0001-8703-1173</a:ResearcherIdentification>
          </a:ResearcherID>
        </a:IndividualIdentification>
      </a:Individual>
      <a:Individual>
        <r:URN>urn:ddi:se.researchdata:doi-10-17044-scilifelab-21557163.Individual-0:2.0</r:URN>
        <a:IndividualIdentification>
          <a:IndividualName>
            <a:FirstGiven>Thoas</a:FirstGiven>
            <a:LastFamily>Fioretos</a:LastFamily>
            <a:FullName>
              <r:String>Thoas Fioretos</r:String>
            </a:FullName>
          </a:IndividualName>
        </a:IndividualIdentification>
      </a:Individual>
    </a:OrganizationScheme>
  </g:ResourcePackage>
  <s:StudyUnit>
    <r:URN>urn:ddi:se.researchdata:doi-10-17044-scilifelab-21557163.StudyUnit:2.0</r:URN>
    <r:UserID typeOfUserID="datasetIdentifier">doi-10-17044-scilifelab-21557163</r:UserID>
    <r:Citation>
      <r:Title>
        <r:String xml:lang="en">RNA-sequencing data from: The AML cellular state space unveils NPM1 immune evasion subtypes with distinct clinical outcomes, and: The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML</r:String>
      </r:Title>
      <r:Creator>
        <r:CreatorReference>
          <r:URN>urn:ddi:se.researchdata:doi-10-17044-scilifelab-21557163.Individual-0:2.0</r:URN>
          <r:TypeOfObject>Individual</r:TypeOfObject>
        </r:CreatorReference>
      </r:Creator>
      <r:Publisher>
        <r:PublisherName>
          <r:String xml:lang="sv">Lunds universitet</r:String>
          <r:String xml:lang="en">Lund University</r:String>
        </r:PublisherName>
      </r:Publisher>
      <r:Publisher>
        <r:PublisherName>
          <r:String xml:lang="sv">Lunds universitet</r:String>
          <r:String xml:lang="en">Lund University</r:String>
        </r:PublisherName>
      </r:Publisher>
      <r:PublicationDate>
        <r:SimpleDate>2025-10-07</r:SimpleDate>
      </r:PublicationDate>
      <r:InternationalIdentifier>
        <r:IdentifierContent>10.17044/SCILIFELAB.21557163</r:IdentifierContent>
        <r:ManagingAgency controlledVocabularyAgencyName="DOI">DOI</r:ManagingAgency>
      </r:InternationalIdentifier>
    </r:Citation>
    <r:Abstract>
      <r:Content xml:lang="en">This dataset contains bulk RNA-sequencing (RNA-seq) gene expression data from from 120 AML-samples from the subtypes NPM1 (n=33), AML-MR (n=30), TP53 (n=18), PML::RARA (n=8), CBFB::MYH11 (n=8), AML without class defining mutations (n=8), RUNX1::RUNX1T1 (n=3), KMT2A fusion genes (n=3), AML meeting the criteria for two subtypes (n=2), DEK-NUP214 (n=2), GATA2::MECOM (n=1), and bialleleic CEBPA mutation (n=1). The single cell libraries were constructed from bone marrow (n=102) or peripheral blood (n=18) using the TruSeq RNA Library Prep Kit v2 (Illumina) and sequenced on a NextSeq 500. Reads were aligned against human reference genome hg19 and read counts were determined using RSEM v1.2.30 (https://github.com/deweylab/RSEM) with gencode v19 as gene reference. Data is available as fpkm-values as determined by RSEM. Raw sequencing reads (fastq) are available at the European Genome-Phenome Archive (EGA) under accession ID EGAD50000001576: https://ega-archive.org/datasets/EGAD50000001576.</r:Content>
    </r:Abstract>
    <r:Coverage>
      <r:TopicalCoverage>
        <r:URN>urn:ddi:se.researchdata:doi-10-17044-scilifelab-21557163.TopicalCoverage:2.0</r:URN>
        <r:Subject xml:lang="en" controlledVocabularyID="3" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Medical and Health Sciences</r:Subject>
        <r:Subject xml:lang="sv" controlledVocabularyID="3" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Medicin och hälsovetenskap</r:Subject>
        <r:Subject xml:lang="en" controlledVocabularyID="30203" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Cancer and Oncology</r:Subject>
        <r:Subject xml:lang="sv" controlledVocabularyID="30203" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Cancer och onkologi</r:Subject>
      </r:TopicalCoverage>
      <r:SpatialCoverage />
    </r:Coverage>
    <a:Archive>
      <r:URN>urn:ddi:se.researchdata:doi-10-17044-scilifelab-21557163.Archive:2.0</r:URN>
      <a:ArchiveSpecific>
        <a:Item>
          <a:Access>
            <r:URN>urn:ddi:se.researchdata:doi-10-17044-scilifelab-21557163.Archive-ArchiveSpecificType-AccessType:2.0</r:URN>
            <a:TypeOfAccess controlledVocabularyName="info:eu-repo-Access-Terms vocabulary"></a:TypeOfAccess>
          </a:Access>
          <a:DataFileQuantity>0</a:DataFileQuantity>
        </a:Item>
      </a:ArchiveSpecific>
    </a:Archive>
  </s:StudyUnit>
</ddi:DDIInstance>